March 2025
Calibre Scientific welcomes Dr. Siddhartha Kadia as Chief Executive Officer
Dr. Kadia brings over two decades of leadership experience in life sciences and diagnostics, with a strong focus on delivering value to customers through growth, innovation, and operational excellence.
Before joining Calibre Scientific, Dr. Kadia served as president and CEO of PhenomeX, a publicly traded biotechnology tools company, guiding it through to its acquisition by Bruker in 2023. Prior to this, he held the role of president and CEO at EAG Laboratories, a private company delivering scientific solutions across diverse industries.
We’re excited to have Dr. Kadia lead us into our next chapter of providing exceptional products, expertise, and services to help you achieve your goals.